-
1
-
-
0036255697
-
Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: Too little, too late
-
11965578 10.1053/jlts.2002.33194
-
Kam I. Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl. 2002;8:347-9.
-
(2002)
Liver Transpl
, vol.8
, pp. 347-349
-
-
Kam, I.1
-
2
-
-
0036249778
-
Right-liver living donor transplantation for decompensated end-stage liver disease
-
11965577 10.1053/jlts.2002.32941
-
Testa G, Malagó M, Nadalin S, Hertl M, Lang H, Frilling A, et al. Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl. 2002;8:340-6.
-
(2002)
Liver Transpl
, vol.8
, pp. 340-346
-
-
Testa, G.1
Malagó, M.2
Nadalin, S.3
Hertl, M.4
Lang, H.5
Frilling, A.6
-
3
-
-
74049088147
-
Live donor liver transplantation in high MELD score recipients
-
19858705 10.1097/SLA.0b013e3181bc9c6a
-
Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, et al. Live donor liver transplantation in high MELD score recipients. Ann Surg. 2010;251:153-7.
-
(2010)
Ann Surg
, vol.251
, pp. 153-157
-
-
Selzner, M.1
Kashfi, A.2
Cattral, M.S.3
Selzner, N.4
McGilvray, I.D.5
Greig, P.D.6
-
4
-
-
34248634598
-
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation
-
17511683 10.1111/j.1600-6143.2007.01802.x 1:STN:280: DC%2BD2szgtFCgsw%3D%3D
-
Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007;7:1601-8.
-
(2007)
Am J Transplant
, vol.7
, pp. 1601-1608
-
-
Fisher, R.A.1
Kulik, L.M.2
Freise, C.E.3
Lok, A.S.4
Shearon, T.H.5
Brown, Jr.R.S.6
-
5
-
-
80053257252
-
Successful use of hepatitis B surface antigen-positive liver grafts in recipients with hepatitis B virus-related liver diseases
-
21748846 10.1002/lt.22379
-
Jiang L, Yan L, Li B, Wen T, Zhao J, Jiang L, et al. Successful use of hepatitis B surface antigen-positive liver grafts in recipients with hepatitis B virus-related liver diseases. Liver Transpl. 2011;17:1236-8.
-
(2011)
Liver Transpl
, vol.17
, pp. 1236-1238
-
-
Jiang, L.1
Yan, L.2
Li, B.3
Wen, T.4
Zhao, J.5
Jiang, L.6
-
6
-
-
77954897950
-
Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin
-
20659092 10.1111/j.1600-6143.2010.03208.x 1:CAS:528:DC%2BC3cXhtFahsbzF
-
Jiang L, Yan L, Li B, Wen T, Zhao J, Jiang L, et al. Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant. 2010;10:1861-9.
-
(2010)
Am J Transplant
, vol.10
, pp. 1861-1869
-
-
Jiang, L.1
Yan, L.2
Li, B.3
Wen, T.4
Zhao, J.5
Jiang, L.6
-
7
-
-
68949086783
-
The Clavien-Dindo classification of surgical complications: Five-year experience
-
19638912 10.1097/SLA.0b013e3181b13ca2
-
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-96.
-
(2009)
Ann Surg
, vol.250
, pp. 187-196
-
-
Clavien, P.A.1
Barkun, J.2
De Oliveira, M.L.3
Vauthey, J.N.4
Dindo, D.5
Schulick, R.D.6
-
8
-
-
44649132697
-
Fulminant hepatitis and late onset hepatic failure in Japan
-
18328067 10.1111/j.1872-034X.2008.00322.x
-
Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2008;38:646-57.
-
(2008)
Hepatol Res.
, vol.38
, pp. 646-657
-
-
Fujiwara, K.1
Mochida, S.2
Matsui, A.3
Nakayama, N.4
Nagoshi, S.5
Toda, G.6
-
9
-
-
67649975639
-
Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft
-
19399732 10.1002/lt.21606
-
Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, et al. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl. 2009;15:496-503.
-
(2009)
Liver Transpl
, vol.15
, pp. 496-503
-
-
Yi, N.J.1
Suh, K.S.2
Lee, H.W.3
Shin, W.Y.4
Kim, J.5
Kim, W.6
-
10
-
-
48549098215
-
Donor morbidity after living donation for liver transplantation
-
18505689 10.1053/j.gastro.2008.04.018
-
Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology. 2008;135:468-76.
-
(2008)
Gastroenterology
, vol.135
, pp. 468-476
-
-
Ghobrial, R.M.1
Freise, C.E.2
Trotter, J.F.3
Tong, L.4
Ojo, A.O.5
Fair, J.H.6
-
11
-
-
0037442204
-
Complications and long-term outcome of living liver donors: A survey of 1,508 cases in five Asian centers
-
12589131 10.1097/01.TP.0000046534.45645.47
-
Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation. 2003;75:S12-5.
-
(2003)
Transplantation
, vol.75
-
-
Lo, C.M.1
-
12
-
-
0041327808
-
Operative morbidity of living liver donors in Japan
-
12957090 10.1016/S0140-6736(03)14230-4
-
Umeshita K, Fujiwara K, Kiyosawa K, Makuuchi M, Satomi S, Sugimachi K, et al. Operative morbidity of living liver donors in Japan. Lancet. 2003;362:687-90.
-
(2003)
Lancet
, vol.362
, pp. 687-690
-
-
Umeshita, K.1
Fujiwara, K.2
Kiyosawa, K.3
Makuuchi, M.4
Satomi, S.5
Sugimachi, K.6
-
13
-
-
3142638650
-
Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation
-
15251354 10.1016/j.transproceed.2004.05.004 1:STN:280: DC%2BD2czkvFGnuw%3D%3D
-
Akyildiz M, Karasu Z, Arikan C, Kilic M, Zeytunlu M, Gunsar F, et al. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation. Transplant Proc. 2004;36:1442-4.
-
(2004)
Transplant Proc.
, vol.36
, pp. 1442-1444
-
-
Akyildiz, M.1
Karasu, Z.2
Arikan, C.3
Kilic, M.4
Zeytunlu, M.5
Gunsar, F.6
-
14
-
-
55949108827
-
Recipient morbidity after living and deceased donor liver transplantation: Findings from the A2ALL Retrospective Cohort Study
-
18976306 10.1111/j.1600-6143.2008.02440.x 1:STN:280: DC%2BD1cjmsVSisg%3D%3D
-
Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008;8:2569-79.
-
(2008)
Am J Transplant
, vol.8
, pp. 2569-2579
-
-
Freise, C.E.1
Gillespie, B.W.2
Koffron, A.J.3
Lok, A.S.4
Pruett, T.L.5
Emond, J.C.6
-
15
-
-
24944586521
-
Outcomes of 385 adult-to-adult living donor liver transplant recipients: A report from the A2ALL Consortium
-
16135918
-
Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242:314-23.
-
(2005)
Ann Surg
, vol.242
, pp. 314-323
-
-
Olthoff, K.M.1
Merion, R.M.2
Ghobrial, R.M.3
Abecassis, M.M.4
Fair, J.H.5
Fisher, R.A.6
-
16
-
-
6444230813
-
Evolving strategies to prevent HBV recurrence
-
15382222 10.1002/lt.20258
-
Roche B, Samuel D. Evolving strategies to prevent HBV recurrence. Liver Transpl. 2004;10:S74-85.
-
(2004)
Liver Transpl
, vol.10
-
-
Roche, B.1
Samuel, D.2
-
17
-
-
20144389066
-
Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B
-
15772792 10.1007/s00595-004-2919-x
-
Kubo S, Tanaka H, Shuto T, Takemura S, Yamamoto T, Kanazawa A, et al. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today. 2005;35:216-22.
-
(2005)
Surg Today
, vol.35
, pp. 216-222
-
-
Kubo, S.1
Tanaka, H.2
Shuto, T.3
Takemura, S.4
Yamamoto, T.5
Kanazawa, A.6
-
18
-
-
17344364991
-
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
-
9696028 10.1002/hep.510280241 1:STN:280:DyaK1czlvFWquw%3D%3D
-
Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology. 1998;28:585-9.
-
(1998)
Hepatology
, vol.28
, pp. 585-589
-
-
Markowitz, J.S.1
Martin, P.2
Conrad, A.J.3
Markmann, J.F.4
Seu, P.5
Yersiz, H.6
-
19
-
-
3042828511
-
Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease
-
12029640 10.1053/jhep.2002.33681
-
Steinmüller T, Seehofer D, Rayes N, Müller AR, Settmacher U, Jonas S, et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology. 2002;35:1528-35.
-
(2002)
Hepatology
, vol.35
, pp. 1528-1535
-
-
Steinmüller, T.1
Seehofer, D.2
Rayes, N.3
Müller, A.R.4
Settmacher, U.5
Jonas, S.6
-
20
-
-
0034948689
-
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis
-
11451175 10.1016/S0168-8278(01)00080-0 1:CAS:528:DC%2BD3MXltlens7s%3D
-
Marzano A, Salizzoni M, Debernardi-Venon W, Smedile A, Franchello A, Ciancio A, et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol. 2001;34:903-10.
-
(2001)
J Hepatol
, vol.34
, pp. 903-910
-
-
Marzano, A.1
Salizzoni, M.2
Debernardi-Venon, W.3
Smedile, A.4
Franchello, A.5
Ciancio, A.6
-
21
-
-
33947304026
-
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
-
17383422 10.1053/j.gastro.2007.01.005 1:CAS:528:DC%2BD2sXkslCjurY%3D
-
Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology. 2007;132:931-7.
-
(2007)
Gastroenterology
, vol.132
, pp. 931-937
-
-
Gane, E.J.1
Angus, P.W.2
Strasser, S.3
Crawford, D.H.4
Ring, J.5
Jeffrey, G.P.6
-
22
-
-
33244474879
-
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis
-
16447195 10.1002/lt.20701
-
Zheng S, Chen Y, Liang T, Lu A, Wang W, Shen Y, et al. Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transpl. 2006;12:253-8.
-
(2006)
Liver Transpl
, vol.12
, pp. 253-258
-
-
Zheng, S.1
Chen, Y.2
Liang, T.3
Lu, A.4
Wang, W.5
Shen, Y.6
-
23
-
-
0035010523
-
Management of hepatitis B: 2000 - Summary of a workshop
-
11375963 10.1053/gast.2001.24839 1:STN:280:DC%2BD3M3ps1Gnsw%3D%3D
-
Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology. 2001;120:1828-53.
-
(2001)
Gastroenterology
, vol.120
, pp. 1828-1853
-
-
Lok, A.S.1
Heathcote, E.J.2
Hoofnagle, J.H.3
-
24
-
-
0033833127
-
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation
-
10959482 10.1111/j.1432-2277.2000.tb01084.x 1:CAS:528: DC%2BD3cXmtlSlsb0%3D
-
Seehofer D, Rayes N, Berg T, Neuhaus R, Müller AR, Hopf U, et al. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation. Transpl Int. 2000;13:290-6.
-
(2000)
Transpl Int
, vol.13
, pp. 290-296
-
-
Seehofer, D.1
Rayes, N.2
Berg, T.3
Neuhaus, R.4
Müller, A.R.5
Hopf, U.6
|